Uterine inversion by a mixed müllerian tumor of the corpus

International Journal of Gynecological Cancer

Volumn 13, Issue 6, 2003, Pages 894-897

  Tjalma, Wiebren A A ^a   Naik, R ^b   Monaghan, J M ^b   De Barros Lopes, A ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Management; Nonpurperal inversion; Sarcoma; Tamoxifen

Indexed keywords

TAMOXIFEN;

ABDOMINAL HYSTERECTOMY; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; LEIOMYOSARCOMA; MIXED MULLERIAN TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; UTERUS INVERSION;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; HUMANS; MIXED TUMOR, MULLERIAN; RISK FACTORS; TAMOXIFEN; UTERINE INVERSION; UTERINE NEOPLASMS;

EID: 1242294394     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2003.13626.x     Document Type: Article

References (25)

1. Gowri V. Uterine inversion and corpus malignancies: a historical review. Obstet Gynecol Surv 2000;55:703-7.
2. Ehrlich CE, Bonaventura LM. Nonpuerperal inversion of the uterus by endometrial stromal sarcoma of the uterine fundus. South Med J 1977;70:872-3.
3. Louw NS, van Schouwenburg J. Inversion of the uterus in a 14-year-old Xhosa girl; case report. S Afr Med J 1980;57:421-2.
4. Henderson PR. A large submucous fibroid polyp causing inversion of the uterus. Aust N Z J Obstet Gynecol 1980;20:251-4.
5. Krenning RA, Dorr PJ, de Groot WH, de Goey WB. Non-puerperal uterine inversion. Case report. Br J Obstet Gynaecol 1982;89:247-9.
6. Saxena K, Kulshreshtha V. Inversion of uterus. J Indian Med Assoca 1985;83:319-20. 328.
7. Lai FM, Tseng P, Yeo SH, Tsakok FH. Non-puerperal uterine inversion-a case report. Singapore Med J 1993;34:466-8.
8. Rattray CA, Parris CN, Chisholm G, Coard KC. Complete non-puerperial uterine inversion as a result of a uterine sarcoma. West Indian Med J 2000;49:245-7.
9. Takano K, Ichikawa Y, Tsunoda H, Nishida M. Uterine inversion caused by uterine sarcoma: a case report. Jpn J Clin Oncol 2001;31:39-42.
10. Skinner GN, Louden KA. Non-puerperal uterine inversion associated with an atypical leiomyoma. Aust N Z J Obstet Gynaecol 2001;41:100-1.
11. Kopal S, Seckin NC, Turhan NO. Acute uterine inversion due to a growing submucous myoma in an elderly woman: case report. Eur J Obstet Gynecol Reprod Biol 2001;99:118-20.
12. Kloos I, Delaloge S, Pautier P et al. Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment. Report of five cases and review of the literature. Int J Gynecol Cancer 2002;12:496-500.
13. McCluggage WG, Abdulkader M, Price JH et al. Uterine carcinosarcomas in patients receiving tamoxifen. A report of 19 cases. Int J Gynecol Cancer 2000;10:280-4.
14. Bernstein L, Deapen D, Cerhan J et al. Tamoxifen therapy for breast cancer and endometrial cancer risk. J Natl Cancer Inst 1999;91:1654-62.
15. Bergman L, Beelen MLR, Gallee MPW et al. Risk and prognosi of endometrial cancerafter tamoxifen for breast cancer. Lancet 2000;356:881-7.
16. Seoud MA, Johnson J, Weed JC Jr. Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 1993;82:165-9.
17. Clarke MR. Uterine malignant mixed mullerian tumor in a patient on long-term tamoxifen therapy for breast cancer. Gynecol Oncol 1993;51:411-5.
18. McCluggage WG, McManus DT, Lioe TF, Hill CM. Uterine carcinosarcoma in association with tamoxifen therapy. Br J Obstet Gynaecol 1997;104:748-50.
19. Treilleux T, Mignotte H, Clement-Chassagne C, Guastalla P, Bailly C. Tamoxifen and malignant epithelial-nonepithelial tumours of the endometrium: report of six cases and review of the literature. Eur J Surg Oncol 1999;25:477-82.
20. Dumortier J, Freyer G, Sasco AJ et al. Endometrial mesodermal mixed tumor occurring after tamoxifen treatment. report on a new case and review of the literature. Ann Oncol 2000;11:355-8.
21. Fotiou S, Hatjieleftheriou G, Kyrousis G, Kokka F, Apostolikas N. Long-term tamoxifen treatment a possible aetiological factor in the development of uterine carcinosarcoma: two case-reports and review of the literature. Anticancer Res 2000;20:2015-20.
22. Le Bouedec G, Auvray H, de Cure H, Latour M, Penault-Llorca F, Dauplat J. Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases. Rev Med Interne 2001;22:881-5.
23. Kaleli S, Calay Z, Altinok T, Kosebay D. Endometrial mixed Mullerian tumor with heterologous elements following tamoxifen therapy for breast cancer. a case report and literature review. Eur J Obstet Gynecol Reprod Biol 2002;101:204-8.
24. McCluggage WG. Uterine carcinosarcoma (malignant mixedMullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer 2002;12:687-90.
25. Banerjee N, Deka D, Roy KK, Takkar D. Inversion of uterus during cesarean section. Eur J Obstet Gynecol Reprod Biol 2000;91:75-7.